Design a syntéza nerapalogových alosterických inhibitorů mTOR

Jan Gebrt

Bakalářská práce

Design and synthesis of non-rapalog allosteric mTOR inhibitors

Abstract:

The Bachelor Thesis focuses on the design and synthesis of substances derived from the compound WRX606 that belongs to the group of so-called non-rapalog inhibitors of mTOR protein complex (mechanistic target of rapamycin) which affects a broad spectrum of signaling pathways in the human body. Dysregulated activity of this complex results in undesirable changes in mentioned cascades leading to the acceleration of cellur senescence and potential development of severe neurodegenerative diseases (Alzheimer’s and Parkinson’s disease) or type 2 diabetes mellitus. Non-rapalog inhibitors represent a group of substances with theoretically favourable pharmacokinetic parameters comparing to previously studied rapamycin. Therefore, further development of compounds from mentioned group and consequent testing of their biological activity can open a path to discovery of new drug candidate applicable in preventative therapy of age-related diseases and prolongation of healthspan.

Keywords

non-rapalog inhibitors, drug development, mTOR, senescence, neurodegenerative diseases, ageing

Jazyk práce: angličtina

Datum vytvoření / odevzdání či podání práce: 9. 5. 2023

Obhajoba závěrečné práce

• Obhajoba proběhla 6. 6. 2023
• Vedoucí: Mgr. Eugenie Nepovimová, Ph.D.
• Oponent: RNDr. Patrik Olekšák, PhD.

Univerzita Hradec Králové

Přírodovědecká fakulta

Bakalářský studijní program / obor:
Chemie / Toxikologie a analýza škodlivin